Further, circulating side channels with anti-PD-1 (programmed cell death protein 1) antibody killed the tumor cells mediated by CD8+-T cells, thus demonstrating that patient-derived organotypic tumor spheroids retaining autologous immune cells can be constructed in microfluidic devices [75,76]. The gene discussed is CD8A; the disease is neoplasm.